The global cell culture market is currently dominated by three major companies who together hold 52% of the market share. Thermo Fisher Scientific ranks on top with 32.9% of the market share, followed by BD Biosciences and EMD Millipore respectively. BD Biosciences has a strong presence in developed economies such as EU5 nations and U.S. Sigma-Aldrich is also a key player in the cell culture consumables business such as media, reagents, and sera. Corning Life Sciences offers economical platforms as compared to other companies. The report finds that high product differentiation plays a major role in determining the market position of the players. A large number of small players are entering the market too, especially in emerging economies, and the outsourcing of cell culture processes to cell culture companies has also increased the competition.
The global cell culture market was valued at US$6.0 bn in 2013 and is projected to reach US$11.3 bn by 2022, expanding at a CAGR of 7.1% during the forecast period.
Geographically, North America accounted for US$2.2 bn in 2013 and is expected to continue as the primary market for cell culture. Asia Pacific is projected to experience the strongest overall growth rate. By product type, consumables had the most significant demand valuation at US$3.4 bn in 2013 and the pattern is anticipated to continue.
Massive Investments Driving Cell Culture Market
Numerous sectors such as research, bioprocessing and manufacturing, academics, and regenerative medicines use cell culture, which has led to a growing demand for these products. As a result, leading pharmaceutical companies are now focusing on increasing their capabilities into biopharmaceutical manufacturing by entering into alliances with biotech companies. For instance, Thermo Fisher Scientific acquired Life Technologies in February 2014 to establish a stronghold over the cell culture market.
Massive capital investments and specificity of each bio-manufacturing process is leading to a shift toward contract manufacturing and research. Furthermore, the expanding scope of cell culture in areas such as stem cell research is also proving to be a positive influence on the market.
Artificial organs are engineered biological substitutes used to replace the structure and restore the functions of an impaired or diseased organ. The market for artificial organs is projected to expand at a double-digit CAGR during the forecast period. Moreover, the trend toward serum-free, specialty and customized media solutions is expected to boost market growth and the applicability of cell culture technology.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
Demand for Advanced Manufacturing Capabilities to Fulfill Requirements
The process of cell culture is complex and requires monitoring several parameters such as temperature, humidity, nutrients, and toxins. Any deviation from the precise handling technique could have an impact on the efficacy of the end product. These constraints are expected to bottleneck the process of cell culture development and manufacturing.
Moreover, the growth of the cell culture market is also likely to be affected by the development of alternative technologies such as transgenic animals and plants for biopharmaceutical production. Ethical concerns over the use of animal sources is another aspect that may curtail the cell culture market growth.
“Cell culture model systems in drug discovery and drug evaluation is opening up significant possibilities for market growth and 3D cell culture is acting as a future opportunity in in vitro analysis too,” reveals the author of the report.
The information presented in this review is based on a Transparency Market Research report, titled, “Cell Culture Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022.”